Skip to Main Content

Open Access: Publishing Agreements

Future Science Group


Available for articles with an acceptance date from 1 January 2022

Journal coverage

  • Bioanalysis
  • Biomarkers in Medicine
  • Epigenomics
  • Future Cardiology
  • Future Medicinal Chemistry
  • Future Microbiology
  • Future Oncology
  • Future Virology
  • Immunotherapy
  • Nanomedicine
  • Neurodegenerative Disease Management
  • Pain Management
  • Personalized Medicine
  • Pharmaceutical Patent Analyst
  • Pharmacogenomics
  • Regenerative Medicine
  • Therapeutic Delivery

Please note: This agreement does not include Future Science Group Gold OA journals.

Eligible article types

Corresponding authors from institutions listed under 'Participating institutions' may publish immediately to open access on the publisher's platform once the article has been accepted, with no transactional APCs. APC-free open access publishing excludes Drug Evaluation articles and content or research that is sponsored or funded by pharmaceutical or biotechnology companies.

Uncapped agreement

This is an uncapped agreement. There is no limit on the number of articles that can be published OA under this agreement.

Other charges

  • Please carefully check individual journal websites for extra charges.

Author rights and licence options

Articles from authors at member institutions will be published under a CC-BY license

How to use this agreement

You will be recognised as being eligible for open access publishing with no transactional APCs via your Deakin email address.

Submit your article via the following links to the publisher's submission system:

Information on publishing in these titles is available at the following links:

Further details

This page provides a summary and was last updated on: 12 Feb 2024

View full details at:

Read & Publish Agreements Negotiated by CAUL: Future Science Group